Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription 12.07.2021 1 Ann Surg 4 Ann Surg Oncol 10 Anticancer Res 3 BMC Cancer 1 BMC Gastroenterol 1 Br J Cancer 2 Br J Surg 1 Cancer 1 Cancer Lett 1 Curr Treat Options Oncol 2 Eur J Surg Oncol 1 Gastroenterology 1 Gastrointest Endosc 1 Int J Colorectal Dis 2 Lancet Oncol 1 N Engl J Med 1 Oncogene 1 PLoS One 5 World J Surg

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg

1. LOUGHREY MB, Webster F, Arends MJ, Brown I, et al
   Dataset for Pathology Reporting of Colorectal Cancer: Recommendations from the International Collaboration on Cancer Reporting (ICCR).
   Ann Surg. 2021 Jul 7. pii: 00000658-900000000-93438.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. MOR E, Assaf D, Laks S, Benvenisti H, et al
   Ratio of Pathological Response to Preoperative Chemotherapy in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer Correlates with Survival.
   Ann Surg Oncol. 2021 Jul 7. pii: 10.1245/s10434-021-10367.
   PubMed         Abstract available
   
   
3. KOBAYASHI S, Nakamura Y, Taniguchi H, Odegaard JI, et al
   Impact of Preoperative Circulating Tumor DNA Status on Survival Outcomes After Hepatectomy for Resectable Colorectal Liver Metastases.
   Ann Surg Oncol. 2021;28:4744-4755.
   PubMed         Abstract available
   
   
4. RAMANATHAN R, Choudry H, Jones H, Girgis M, et al
   Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-alpha, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases.
   Ann Surg Oncol. 2021;28:4637-4646.
   PubMed         Abstract available
   
   
5. VERTER E, Berger Y, Perl G, Peretz I, et al
   Neutrophil-to-Lymphocyte Ratio Predicts Recurrence Pattern in Patients with Resectable Colorectal Liver Metastases.
   Ann Surg Oncol. 2021;28:4320-4329.
   PubMed         Abstract available
   
   

   
   Anticancer Res

6. CHEN IY, Findeis-Hosey JJ, Cannon L, Liao X, et al
   Primary Colonic Medullary Carcinoma With Exclusive Squamous Differentiation.
   Anticancer Res. 2021;41:3567-3572.
   PubMed         Abstract available
   
   
7. KUBO H, Ikoma H, Yamamoto Y, Morimura R, et al
   Therapeutic Strategy of Colorectal Liver Metastasis Using Modified-JHBPS Nomogram.
   Anticancer Res. 2021;41:3657-3665.
   PubMed         Abstract available
   
   
8. SHIBUTANI M, Maeda K, Kashiwagi S, Nagahara H, et al
   Lactate Dehydrogenase Is a Useful Marker for Predicting the Efficacy of Bevacizumab-containing Chemotherapy in Patients With Metastatic Colorectal Cancer.
   Anticancer Res. 2021;41:3535-3542.
   PubMed         Abstract available
   
   
9. RUBIO CA, Schmidt PT
   Crypts in Asymmetric Fission in Endoscopic Biopsies from Swedish Patients With Inflammatory Bowel Disease.
   Anticancer Res. 2021;41:3511-3517.
   PubMed         Abstract available
   
   
10. LIM JH, Go G, Lee SH
    PrPC Regulates the Cancer Stem Cell Properties via Interaction With c-Met in Colorectal Cancer Cells.
    Anticancer Res. 2021;41:3459-3470.
    PubMed         Abstract available
    
    
11. HIROSHIMA Y, Ishikawa H, Murakami M, Nakamura M, et al
    Proton Beam Therapy for Local Recurrence of Rectal Cancer.
    Anticancer Res. 2021;41:3589-3595.
    PubMed         Abstract available
    
    
12. SHIBUTANI M, Maeda K, Kashiwagi S, Hirakawa K, et al
    Effect of Adjuvant Chemotherapy on Survival of Elderly Patients With Stage III Colorectal Cancer.
    Anticancer Res. 2021;41:3615-3624.
    PubMed         Abstract available
    
    
13. DE ANGELIS PM, Dorg L, Pham S, Andersen SN, et al
    DNA Repair Protein Expression and Oxidative/Nitrosative Stress in Ulcerative Colitis and Sporadic Colorectal Cancer.
    Anticancer Res. 2021;41:3261-3270.
    PubMed         Abstract available
    
    
14. KIM J, Baek DW, Baek JH, Kang BW, et al
    Clinical Impact of Postoperative Vitamin D Deficiency on the Recurrence of Colon Cancer After Curative Surgical Resection.
    Anticancer Res. 2021;41:3683-3688.
    PubMed         Abstract available
    
    
15. MATSUI H, Homma S, Hatanaka KC, Sawada A, et al
    Novel Prognostic Stratification Factor Based on the Pathological Profile of the Invasive Front in Colorectal Cancer.
    Anticancer Res. 2021;41:3429-3438.
    PubMed         Abstract available
    
    

    
    BMC Cancer

16. FU Y, Chen X, Song Y, Huang X, et al
    The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer.
    BMC Cancer. 2021;21:792.
    PubMed         Abstract available
    
    
17. FU D, Ren Y, Wang C, Yu L, et al
    LINC01287 facilitates proliferation, migration, invasion and EMT of colon cancer cells via miR-4500/MAP3K13 pathway.
    BMC Cancer. 2021;21:782.
    PubMed         Abstract available
    
    
18. SHANG W, Yan C, Liu R, Chen L, et al
    Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis.
    BMC Cancer. 2021;21:770.
    PubMed         Abstract available
    
    

    
    BMC Gastroenterol

19. WANG J, Long Y, Liu K, Pei Q, et al
    Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer.
    BMC Gastroenterol. 2021;21:277.
    PubMed         Abstract available
    
    

    
    Br J Cancer

20. HUA X, Kratz M, Malen RC, Dai JY, et al
    Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients.
    Br J Cancer. 2021 Jul 6. pii: 10.1038/s41416-021-01458.
    PubMed         Abstract available
    
    

    
    Br J Surg

21. GONELLA F, Massucco P, Perotti S, Monasterolo S, et al
    Telemedicine prehabilitation as a result of COVID-19: disruptive technological solutions.
    Br J Surg. 2021;108:e215-e216.
    PubMed        
    
    
22. SPYCHALSKI M, Wlodarczyk M, Winter K
    Impact of COVID-19 pandemic on endoscopic submucosal dissection outcomes in early colorectal tumours.
    Br J Surg. 2021;108:e224-e225.
    PubMed        
    
    

    
    Cancer

23. BOEHMER U, Ozonoff A, Winter M, Berklein F, et al
    Health-related quality of life among colorectal cancer survivors of diverse sexual orientations.
    Cancer. 2021 Jul 8. doi: 10.1002/cncr.33762.
    PubMed         Abstract available
    
    

    
    Cancer Lett

24. JING Z, He X, Jia Z, Sa Y, et al
    NCAPD2 inhibits autophagy by regulating Ca(2+)/CAMKK2/AMPK/mTORC1 pathway and PARP-1/SIRT1 axis to promote colorectal cancer.
    Cancer Lett. 2021;520:26-37.
    PubMed         Abstract available
    
    

    
    Curr Treat Options Oncol

25. DIEHL TM, Abbott DE
    Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic Colorectal Cancer.
    Curr Treat Options Oncol. 2021;22:82.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

26. PELLINO G, Garcia-Granero E, Cervantes A
    Peritoneal invasion and metachronous peritoneal metastases after colon cancer surgery: The role of homogeneous, reliable assessment and confounders.
    Eur J Surg Oncol. 2021 Jun 29. pii: S0748-7983(21)00596.
    PubMed        
    
    
27. BASTIAENEN VP, Tanis PJ
    Reply to: Peritoneal invasion and metachronous peritoneal metastases after colon cancer surgery: The role of homogeneous, reliable assessment and confounders.
    Eur J Surg Oncol. 2021 Jun 30. pii: S0748-7983(21)00595.
    PubMed        
    
    

    
    Gastroenterology

28. ZHAI LL, Zhu AK, Tang ZG
    Noninvasive identification of lymph node metastasis in T1 colorectal cancer by transcriptomic panel based on liquid biopsy assay: additional analytical strategies are needed.
    Gastroenterology. 2021 Jul 2. pii: S0016-5085(21)03231.
    PubMed        
    
    

    
    Gastrointest Endosc

29. LI B, Shi Q, Xu EP, Yao LQ, et al
    Prediction of technically difficult endoscopic submucosal dissection for large superficial colorectal tumors: a novel clinical score model.
    Gastrointest Endosc. 2021;94:133-144.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

30. ARNAL MJD, Mateo SG, Hermoso-Duran S, Abad D, et al
    Correction to: False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use.
    Int J Colorectal Dis. 2021 Jul 6. pii: 10.1007/s00384-021-03965.
    PubMed        
    
    

    
    Lancet Oncol

31. VOS JAM, Duineveld LAM, Wieldraaijer T, Wind J, et al
    Effect of general practitioner-led versus surgeon-led colon cancer survivorship care, with or without eHealth support, on quality of life (I CARE): an interim analysis of 1-year results of a randomised, controlled trial.
    Lancet Oncol. 2021 Jul 2. pii: S1470-2045(21)00273.
    PubMed         Abstract available
    
    
32. ANGENETE E
    Who should manage post-treatment care for patients with colon cancer: surgeons or general practitioners?
    Lancet Oncol. 2021 Jul 2. pii: S1470-2045(21)00379.
    PubMed        
    
    

    
    N Engl J Med

33. AWAD MM, Liu S, Rybkin II, Arbour KC, et al
    Acquired Resistance to KRAS(G12C) Inhibition in Cancer.
    N Engl J Med. 2021;384:2382-2393.
    PubMed         Abstract available
    
    

    
    Oncogene

34. RUAN DY, Li T, Wang YN, Meng Q, et al
    FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis.
    Oncogene. 2021 Jul 3. pii: 10.1038/s41388-021-01916.
    PubMed         Abstract available
    
    

    
    PLoS One

35. KHARIN L, Bychkov I, Karnaukhov N, Voloshin M, et al
    Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression.
    PLoS One. 2021;16:e0252132.
    PubMed         Abstract available
    
    

    
    World J Surg

36. ASKLID D, Ljungqvist O, Xu Y, Gustafsson UO, et al
    Risk Factors for Anastomotic Leakage in Patients with Rectal Tumors Undergoing Anterior Resection within an ERAS Protocol: Results from the Swedish ERAS Database.
    World J Surg. 2021;45:1630-1641.
    PubMed         Abstract available
    
    
37. KOJIMA K, Shindoh J, Akabane M, Umino R, et al
    Usefulness of Serum Anti-p53 Antibody Measurement in Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
    World J Surg. 2021;45:1906-1912.
    PubMed         Abstract available
    
    
38. CHRISTOU N, Meyer J, Combescure C, Balaphas A, et al
    Prevalence of Metastatic Lateral Lymph Nodes in Asian Patients with Lateral Lymph Node Dissection for Rectal Cancer: A Meta-analysis.
    World J Surg. 2021;45:1537-1547.
    PubMed         Abstract available
    
    
39. KAWAMURA H, Ogawa Y, Yamazaki H, Honda M, et al
    Impact of Primary Tumor Resection on Mortality in Patients with Stage IV Colorectal Cancer with Unresectable Metastases: A Multicenter Retrospective Cohort Study.
    World J Surg. 2021 Jul 5. pii: 10.1007/s00268-021-06233.
    PubMed         Abstract available
    
    
40. KIM M, Kim CW, Hwang S, Kim YH, et al
    Characteristics and Prognosis of Colorectal Cancer after Liver or Kidney Transplantation.
    World J Surg. 2021 Jul 7. pii: 10.1007/s00268-021-06219.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: